Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose.

Am J Physiol Endocrinol Metab

Clinical Research Unit for Gastrointestinal Endocrinology, Department of Internal Medicine, Philipps University, 35033 Marburg, Germany.

Published: April 2002

AI Article Synopsis

  • The study investigates how acute hyperglycemia affects beta-cell function in response to glucose changes.
  • Healthy volunteers received two different glucose infusions: low-dose and high-dose, with results showing significantly higher glucose and insulin levels during high-dose infusions.
  • Higher glucose levels led to reduced regularity in glucose, insulin secretion, and insulin oscillations, suggesting hyperglycemia may contribute to beta-cell response impairments seen in IGT and NIDDM.

Article Abstract

Impaired glucose tolerance (IGT) and non-insulin-dependent diabetes mellitus (NIDDM) are associated with an impaired ability of the beta-cell to sense and respond to small changes in plasma glucose. The aim of this study was to establish whether acute hyperglycemia per se plays a role in inducing this defect in beta-cell response. Seven healthy volunteers with no family history of NIDDM were studied on two occasions during a 12-h oscillatory glucose infusion with a periodicity of 144 min. Once, low-dose glucose was infused at a mean rate of 6 mg x kg(-1) x min(-1) and amplitude 33% above and below the mean rate, and, once, high-dose glucose was infused at 12 mg x kg(-1) x min(-1) and amplitude 16% above and below the mean rate. Mean glucose levels were significantly higher during the high-dose compared with the low-dose glucose infusion [9.5 +/- 0.8 vs. 6.8 +/- 0.2 mM (P < 0.01)], resulting in increased mean insulin secretion rates [ISRs; 469.1 +/- 43.8 vs. 268.4 +/- 29 pmol/min (P < 0.001)] and mean insulin levels [213.6 +/- 46 vs. 67.9 +/- 10.9 pmol/l (P < 0.008)]. Spectral analysis evaluates the regularity of oscillations in glucose, insulin secretion, and insulin at a predetermined frequency. Spectral power for glucose, ISR, and insulin was reduced during the high-dose glucose infusion [11.8 +/- 1.4 to 7.0 +/- 1.6 (P < 0.02), 7.6 +/- 1.5 to 3.2 +/- 0.5 (P < 0.04), and 10.5 +/- 1.6 to 4.6 +/- 0.7 (P < 0.01), respectively]. In conclusion, short-term infusion of high-dose glucose to obtain glucose levels similar to those previously seen in IGT subjects results in reduced spectral power for glucose, ISR, and insulin. The reduction in spectral power previously observed for ISR in IGT or NIDDM subjects may be due partly to hyperglycemia.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00427.2001DOI Listing

Publication Analysis

Top Keywords

+/- +/-
16
glucose
14
glucose infusion
12
high-dose glucose
12
+/-
12
spectral power
12
acute hyperglycemia
8
beta-cell sense
8
sense respond
8
low-dose glucose
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!